KalVista Pharmaceuticals, Inc.
HealthcareNASDAQ:KALV · NASDAQ Global Market
+$0.00 today
Vol 4.26M · Avg 3.47M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+108.33%
Period High
$27.00
Period Low
$10.76
Latest
$27.00
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
$862.12M
Omeros Corporation
NASDAQ:OMER
$632.20M
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
$607.79M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$461.60M
Prothena Corporation plc
NASDAQ:PRTA
$431.91M
Verastem, Inc.
NASDAQ:VSTM
$284.19M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
Gossamer Bio, Inc.
GOSS
$38.00M
What is the latest KALV filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does KALV have?
Intrinsic Alpha currently shows 20 recent filings for KALV.
Explore More
Continue the stock analysis
Jump to another research area for this company.